X4 Pharmaceuticals (XFOR) Stock Price

$0.467 0%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    10
  • Fundamental

    1
  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on X4 Pharmaceuticals, AI stock picks, stock alerts and much more.

Sign up

XFOR AI Stock Analysis

AI stock analysis for XFOR is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like X4 Pharmaceuticals (XFOR) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

X4 Pharmaceuticals (XFOR) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of X4 Pharmaceuticals (XFOR), currently trading at $0.467, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About XFOR

LSE
  • X4 Pharmaceuticals, Inc.

  • Symbol

    XFOR

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    79.7M

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX
$21.62
2%
6
INO Inovio Pharmaceuticals
INO
$2.24
0.9%
2
MRNA Moderna
MRNA
$35.53
5.3%
4
AVXL Anavex Life Sciences
AVXL
$8.35
3.8%
6
BBIO BridgeBio Pharma
BBIO
$36.85
0.1%
6

XFOR Alternative Data

Web Traffic

X4 Pharmaceuticals receives an estimated 5041 monthly visitors to x4pharma.com.

  • Web Traffic

    5041

  • Change from Previous Month

    4%

  • 3 Month Change

    25.7%

  • YoY Change

    25.7%

News Mentions

X4 Pharmaceuticals was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

Reddit Mentions

X4 Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

Twitter Followers

X4 Pharmaceuticals has 1,027 Twitter Followers on its main Twitter (also known as X) account, which is up by 2.4% over the last month.

  • Twitter Followers

    1027

  • Daily Change

    0.2%

  • 1 Month Change

    2.4%

  • 3 Month Change

    2.7%

LinkedIn Followers

12,237 are following X4 Pharmaceuticals on LinkedIn, up by 3.3% over the last month.

  • LinkedIn Followers

    12237

  • Daily Change

    0.1%

  • 1 Month Change

    3.3%

  • 3 Month Change

    7.4%

Job Postings

X4 Pharmaceuticals has an estimated 4 open job postings, which is down -20% over the last month.

  • Job Postings

    4

  • Daily Change

    0%

  • 1 Month Change

    20%

  • 3 Month Change

    60%

LinkedIn Employees

According to LinkedIn, X4 Pharmaceuticals has 145 employees, down by -0.7% over the last month.

  • LinkedIn Employees

    145

  • Daily Change

    0%

  • 1 Month Change

    0.7%

  • 3 Month Change

    7.4%

Business Outlook
  • Business Outlook

    88

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

XFOR Financials

XFOR Key Metrics
  • Total Revenue

    $560K

  • Net Income

    -$36.7M

  • Earnings per Share

    -$0.18

  • Free cash flow

    -$34.1M

  • EBITDA

    -$34M

  • EBITDA Ratio

    -60.7143

  • Total Assets

    $178.2M

XFOR 2-year Revenue & Income
XFOR 2-year Free Cash Flow

XFOR Technicals

XFOR SMA
XFOR RSI

FAQ

What's the current price of X4 Pharmaceuticals (XFOR) Stock?
The price of an X4 Pharmaceuticals (XFOR) share is $0.467.

What's the market cap of X4 Pharmaceuticals?
The current market cap of X4 Pharmaceuticals is 79.7M.

Should I buy or sell XFOR?
X4 Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, X4 Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.

Is X4 Pharmaceuticals a good investment?
The current analysis of X4 Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in X4 Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy X4 Pharmaceuticals (XFOR) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for X4 Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to X4 Pharmaceuticals (XFOR) that investors often compare it to?
X4 Pharmaceuticals (XFOR) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for X4 Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast X4 Pharmaceuticals' stock price to be around $0.473 in 2026. Starting from the current price of $0.467, this represents a 1.3% change in price, indicating a neutral outlook for the stock.

How to buy X4 Pharmaceuticals (XFOR) Stock?
X4 Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy X4 Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.